The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
LOTUS: A randomized, phase II, multicenter, placebo-controlled study of ipatasertib (Ipat, GDC-0068), an inhibitor of Akt, in combination with paclitaxel (Pac) as front-line treatment for patients (pts) with metastatic triple-negative breast cancer (TNBC).
 
Sung-Bae Kim
No Relationships to Disclose
 
Antoinette R. Tan
Research Funding - Abbvie (Inst); Bayer/Onyx (Inst); Eisai (Inst); Genentech (Inst); GlaxoSmithKline (Inst); ImClone Systems (Inst); Merck (Inst); Nektar (Inst)
 
Seock-Ah Im
No Relationships to Disclose
 
Rafael Villanueva
No Relationships to Disclose
 
Vicente Valero
No Relationships to Disclose
 
Cristina Saura
No Relationships to Disclose
 
Mafalda Oliveira
No Relationships to Disclose
 
Steven J. Isakoff
Consulting or Advisory Role - BIND Biosciences; Myriad Genetics
Research Funding - Abbvie; Genentech; PharmaMar
Travel, Accommodations, Expenses - Genentech; Myriad Genetics; Myriad Genetics
 
Stina Mui Singel
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
 
Rebecca Alexandra Dent
No Relationships to Disclose